#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Osteosarcoma recurrent Hypergammaglobulinaemia benign monoclonal Spinal cord injury Hyperadrenocorticism Burkitt's lymphoma Acute lymphocytic leukaemia recurrent Mitochondrial DNA depletion Extra-osseous Ewing's sarcoma Dermatomyositis Autoimmune demyelinating disease Obliterative bronchiolitis Craniopharyngioma Ovarian cancer stage III Plasma cell myeloma recurrent Adenocarcinoma gastric More trials…

    Learn about Rare Diseases

    Castleman’s disease – Treatment Tuberous sclerosis complex – Life with Disease Bronchopulmonary dysplasia – Basic Information Hereditary ataxia – Treatment Fragile X syndrome Rosai-Dorfman syndrome – Basic Information Myxofibrosarcoma – Trials in Disease Rosai-Dorfman syndrome – Life with Disease Pituitary-dependent Cushing’s syndrome – Trials in Disease Langerhans’ cell histiocytosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ARTICAINE HYDROCHLORIDE Prednisolone Sodium Phosphate Alprazolam Budigalimab Cholic Acid Eribulin Mesylate ZIGAKIBART Belimumab Piflufolastat (18F) Deutivacaftor SP16 Progesterone, Micronised ZIRCONIUM (89ZR) GIRENTUXIMAB Estriol Zilovertamab Vedotin Magnesium [18F]Mc225 BRENSOCATIB Secukinumab Delandistrogene Moxeparvovec More therapies…

    Learn about Your Condition

    Infection Insomnia Ovarian cancer stage IV Gastrointestinal melanoma Migraine without aura Influenza Oxygen saturation Albright's disease Neonatal respiratory failure Primary hypercholesterolaemia Biliary cancer metastatic Peripheral artery thrombosis Body mass index increased Myxoid liposarcoma Sleep disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Bp 96031, Rouen, 76031, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Repotrectinib for Frail or Elderly Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Rearrangement

    Recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Repotrectinib
    France

  • Study on Nifedipine for Managing Preterm Premature Rupture of Membranes (PPROM) in Pregnant Women Before 34 Weeks

    Recruiting

    3 1 1
    Investigated Diseases:
    • Premature rupture of membranes
    Investigated Drugs:
    • Nifedipine
    France

  • Study on the Effects of Ketoprofen and Drug Combination in Patients Undergoing Pleurodesis Surgery for Pneumothorax

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pneumothorax
    Investigated Drugs:
    • Tramadol
    • Nefopam
    • Cellulose, Microcrystalline
    France

  • Study on the Effect of Clobetasol Propionate on Bone Mineral Density in Patients with Bullous Pemphigoid

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Clobetasol Propionate
    France

  • Study of Dostarlimab Combined with Short Course Radiotherapy for Locally Advanced Rectal Cancer Patients with Microsatellite Instability

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Microsatellite instability cancer
    • Rectal cancer
    Investigated Drugs:
    • Dostarlimab
    France

  • Study on the Early Use of Levosimendan Compared to Placebo for Patients with Cardiogenic Shock

    Recruiting

    3 1 1
    Investigated Drugs:
    • Biotin
    • Pantothenate Sodium
    • Riboflavin Sodium Phosphate
    France

  • Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dermatomyositis
    • Polymyositis
    Investigated Drugs:
    • Anifrolumab
    Austria Belgium Bulgaria Czechia Denmark France +7

  • Study of caspofungin compared to placebo for treating yeast infections in the abdomen in intensive care unit patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Peritonitis
    • Fungal infection
    Investigated Drugs:
    • Caspofungin
    • Sodium Chloride
    France

  • Study on Preventing Cytomegalovirus Infection Using Valganciclovir in Kidney Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Valganciclovir
    France

  • Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Oxaliplatin
    France
Previous Page
1 … 7 8 9 10 11 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!